[Skip to Navigation]
Sign In
Viewpoint
August 2, 2021

Two Models of Legalization of Psychedelic Substances: Reasons for Concern

Author Affiliations
  • 1Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 2Scattergood Program for Applied Ethics of Behavioral Health Care, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 3Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York
  • 4Center for Law, Ethics and Psychiatry, New York State Psychiatric Institute, New York
JAMA. 2021;326(8):697-698. doi:10.1001/jama.2021.12481
Add or change institution
×